Spatial Transcriptomics Market To Reach $902.2 Million By 2030

Spatial Transcriptomics Market Growth & Trends

The global spatial transcriptomics market is anticipated to reach USD 902.2 million by 2030, exhibiting a CAGR of 15.23% from 2024 to 2030, according to a new report by Grand View Research, Inc. The rising potential of spatial omics analysis as a cancer tool increased the demand for spatial transcriptomics, continuous advancements in spatial transcriptomics technologies, and the expanding field of drug discovery and development are anticipated to increase the demand for spatial transcriptomics over the forecast period.

Moreover, there is continued integration of AI and ML in various industries, including healthcare, finance, and manufacturing. The industry is witnessing advancements in natural language processing, computer vision, and reinforcement learning. In healthcare, AI-driven spatial analysis can enhance the precision of mapping disease outbreaks, optimizing resource allocation, and predicting patient outcomes based on geographical data. Thus, as AI and ML continue to evolve, their application in spatial analysis is expected to drive significant growth and innovation across various industries, leveraging the power of spatial data to enhance decision-making and operational efficiency. Thereby impelling the growth of the spatial transcriptomics market over the foreseeable future.

However, analyzing spatial transcriptomics data requires specialized computational tools and expertise. The interpretation of large-scale spatial datasets presents challenges related to data management, integration, and visualization. The high costs associated with instruments, reagents, and data analysis can pose a barrier to entry for some researchers and is anticipated to hamper the growth of the market.

 Request a free sample copy or view report summary: Spatial Transcriptomics Market Report

Spatial Transcriptomics Market Report Highlights

• The consumables segment dominated the product segment with the highest revenue share of 52.73% in 2023. This is attributed to the high product penetration and high usage of kits & reagents. On the other hand, software is expected to grow at the fastest rate over the forecast period.

• The sequencing-based methods segment held the largest market share of 53.61% in 2023 for the technology segment and is anticipated to grow at the fastest rate over the forecast period. This is attributed to the growing interest in using spatial transcriptomics for cancer research, developmental biology, neuroscience, and disease pathology.

• Based on workflow, instrumental analysis dominated the segment with the largest revenue share of 47.02% in 2023 and is anticipated to grow at the highest CAGR over the forecast period. However, sample preparation is expected to grow significantly from 2024 to 2030.

• Based on sample type, FFPE dominated the segment with the largest revenue share of 63.30% in 2023. On the other hand, fresh frozen is expected to grow at the fastest rate over the forecast period.

• Based on end use, translational research dominated the segment with the largest revenue share of 56.63% in 2023 and is anticipated to grow at the highest CAGR over the forecast period. This is attributed to the growing R&D activities, increasing demand for personalized medicines, and growing technological advancements.

• The North American region dominated the market share of 57.73% in 2023 due to its robust healthcare infrastructure, high adoption rates of advanced medical technologies, and significant investments in biopharmaceutical research and development. On the other hand, Asia Pacific anticipated growing at the highest CAGR over the forecast period.

Spatial Transcriptomics Market Segmentation

Grand View Research has segmented the global spatial transcriptomics market based on product, technology, workflow, sample type, end-use, and region:

Spatial Transcriptomics Product Outlook (Revenue, USD Million, 2018 - 2030)

• Instruments

  • By Mode

    • Automated

    • Semi-automated

    • Manual

  • By Type

    • Sequencing Platforms

    • IHC

    • Microscopy

    • Flow Cytometry

    • Mass Spectrometry

    • Others

• Consumables

• Software

  • Bioinformatics Tools

  • Imaging Tools

  • Storage And Management Databases

Spatial Transcriptomics Technology Outlook (Revenue, USD Million, 2018 - 2030)

• Sequencing-based Methods

  • Laser Capture Microdissection (LCM)

  • Transcriptome In-Vivo Analysis (TIVA)

  • In Situ Sequencing

  • Microtomy Sequencing

• IHC

• Microscopy-based RNA Imaging Techniques

  • Single Molecule RNA Fluorescence In-Situ Hybridization (smFISH)

  • Padlock Probes/ Rolling Circle Amplification

  • Branched DNA Probes

Spatial Transcriptomics Workflow Outlook (Revenue, USD Million, 2018 - 2030)

• Sample Preparation

• Instrumental Analysis

• Data Analysis

Spatial Transcriptomics Sample Type Outlook (Revenue, USD Million, 2018 - 2030)

• FFPE

• Fresh Frozen

Spatial Transcriptomics End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Translational Research

• Academic Customers

• Diagnostic Customers

• Pharmaceutical Manufacturer

Spatial Transcriptomics Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • Thailand

  • South Korea

• Latin America

  • Brazil

  • Argentina

• Middle East and Africa (MEA)

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in the Spatial Transcriptomics Market

• Illumina, Inc.

• NanoString Technologies, Inc.

• 10x Genomics.

• Cantata Bio

• Bruker

• EVOSEP

• Shimadzu Corporation

• Waters

• Horizon Discovery Group plc

• Bio-Techne